Connect with us

Business

Once Washed Dishes, Now Owns 250 Restaurants: Incredible Journey Of An Indian In The US

Published

on

Once Washed Dishes, Now Owns 250 Restaurants: Incredible Journey Of An Indian In The US


Last Updated:

Amol Kohli, once a dishwasher at a restaurant in the US, now owns the chain and its parent Brix Holdings, leading a revival of the iconic brand and six others across 250 outlets

Amol Kohli went from starting as a dishwasher to becoming a restaurant tycoon. (News18 Hindi)

Amol Kohli went from starting as a dishwasher to becoming a restaurant tycoon. (News18 Hindi)

It reads like the script of an inspiring biopic, a 15-year-old boy washing dishes and cleaning tables at a local diner in the United States, struggling to make ends meet, only to return decades later as the owner of that very restaurant chain. But this isn’t fiction. This is the extraordinary story of Amol Kohli, an Indian-origin entrepreneur who has turned his life around through sheer grit and determination.

In 2003, a young Amol Kohli worked part-time at a Friendly’s restaurant in the United States. He was then a high school student, earning $5 an hour, juggling studies with long hours of cleaning, cooking, and serving customers. “There wasn’t a specific role for me,” he once said in an interview, adding that he did whatever his manager asked, whether it was washing plates or taking out the trash.

Two decades later, the tables have quite literally turned. Kohli’s investment group has acquired Friendly’s and its parent company, Brix Holdings, along with six other popular restaurant brands. While the value of the transaction remains undisclosed, industry insiders estimate the deal to be worth billions of dollars.

Kohli’s journey from a waiter to a business magnate began with lessons learned on the job. After graduating from Drexel University with a degree in finance and marketing, he channelled his experience at Friendly’s into entrepreneurship. “Everything I know about running a business, from calculating food costs to managing insurance, I learned while I was still a student,” he said.

Over the years, Kohli built a formidable restaurant empire. Today, he owns around 250 outlets across the United States and oversees multiple brands, including Clean Juice, Orange Leaf, Red Mango, Smoothie Factory Plus Kitchen, Super Salad, and Humble Donut.

But his biggest emotional triumph remains the acquisition of Friendly’s, the same restaurant chain where his journey began. Kohli’s company has now taken control of all 31 remaining Friendly’s locations, aiming to revive the brand that has seen turbulent times in recent years.

Founded in 1935, Friendly’s once operated more than 800 outlets across the US. However, the chain struggled financially, and after the Covid-19 pandemic-induced collapse of the hospitality sector in 2020, it was forced into bankruptcy, eventually being sold to Brix Holdings for just $2 million.

Now, under Kohli’s leadership, the brand is set for a new chapter.

News business Once Washed Dishes, Now Owns 250 Restaurants: Incredible Journey Of An Indian In The US
Disclaimer: Comments reflect users’ views, not News18’s. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Read More



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Pensioners Alert! Govt Asks Banks To Provide Pension Slip To Govt Employees On Monthly Basis

Published

on

Pensioners Alert! Govt Asks Banks To Provide Pension Slip To Govt Employees On Monthly Basis


New Delhi: The Department of Pension & Pensioner’s Welfare (DoPPW) under the Ministry of Personnel, PG & Pensions has issued its latest Office Memorandum regarding Pension Payment Slip to all Central Civil Pensioners/Family Pensioners on monthly basis.

In its OM, the DoPPW has asked all banks to adhere to its previous order on issuance of pension slip. DoPPW highlighted that grievances are being still received in this office from Pensioners/Family Pensioners about the non-receipt of Pension Payment Slip.

“All CPPCs of Authorised Banks are once again instructed to invariably provide the pension payment slip to all central civil pensioners and family pensioners after credit of pension/family pension through various available modes including email,” DoPPW said. 

Add Zee News as a Preferred Source


The DoPPW further said that if email is not available, the same may be obtained from the pensioner so that the pension slip can be sent through e-mail also.



Source link

Continue Reading

Business

OBR head’s resignation leaves potential landmines for Reeves

Published

on

OBR head’s resignation leaves potential landmines for Reeves


The shock resignation came for a very specific reason, but the OBR saga will continue with a series of decisions the chancellor will have to make over Richard Hughes’ replacement.

Firstly the Chancellor will have to find a respected and credible economist to run the OBR.

There are several candidates, who might fit the mould of fiercely independent bean counters.

The list will be carefully watched by the markets for any departure from the normal model. The problem is that there is some political pressure to do just that.

One of the points of tension was the refusal of Richard Hughes to give credit to the Government for “pro growth” policies.

Mr Hughes had said he would not score any policy unless it was material in its impact on the economy. In the event, none reached the 0.1% of national income threshold.

It is a careful balancing act, however.

Any perceived interference with the OBRs independence could impact market credibility too, and, for example raise UK government borrowing costs.

When I saw the now-departing chairman on the evening of the Budget last week, he was clearly mortified by the responsibility of his organisation for the early release of Budget information.

While it is no surprise to me that Mr Hughes took the honourable decision to resign for an error identified as the fault of a junior member of staff, it was not the only issue vexing him.

He was a fierce defender of the independence of his organisation from political and ministerial pressure – from right and left. That was seen during the Liz Truss mini budget episode, and in recent weeks too.

There had been a drumbeat of noise from the right, and the left and now from the centre too about the restrictions the OBR system placed on the freedoms of elected Governments.

The OBR was in some corners seen as an arm of a “woke deep state”, and by others as an “agent of austerity”.

There had, however, been tension over the Budget.

Changes had already been planned. The Chancellor had also announced that it would only respond to the OBR’s forecasts once a year.

Mr Hughes told me: “We’ll still be producing two full economic and fiscal forecasts looking five years out, twice a year, now and in the spring.

“But with this change of legislation, the government doesn’t feel obliged to respond to those forecasts with policy in the spring. It’ll be more like a health check on the economy and the public finances.

“There’ll be no loss of transparency from the forecast documentation that we’ll produce.”

The precise design of the new approach to the OBR’s forecast will matter. If there is a marked improvement in the public finances in spring, will the chancellor really avoid spending any “surplus” ahead of crucial local elections?

The OBR did around the Budget score an improvement to the UK economy as a deployment of AI by the end of the decade. The OBR also used new powers to initiate a tricky costing for the ballooning cost of special educational needs in England, inviting a backlash from some Cabinet ministers.

For some this underscores its ability like no campaign or Cabinet minister initiative, to focus Government priorities. Hughes denied the 35-member forecasting group was too powerful.

“The powers given to us are those given to us by Parliament in an Act of Parliament, and that’s to produce a forecast. Chancellors set their own targets. They set their own policies. Chancellors are in charge of £1.5 trillion worth of revenue and £1.5 trillion worth of spending.

“If they don’t want to meet their targets, they can change them, which we’ve seen chancellors do in the past as well. All we do is produce a baseline forecast, cost government policies when they give them to us, and we give them an assessment about whether we’re up there, in line and on track to meet those targets,” he told me.

In terms of the Government’s difficulties over the run up to this Budget, Mr Hughes may also take some important details of the timing of various claims around the state of the public finances to his gardening leave.

He had been due to address the Treasury Select Committee this morning, that has now been cancelled. He recognised the publication of his clarification table on Friday of the evolution of the forecasts was unusual.

Over five years at the OBR Richard Hughes faced five chancellors, and his relationship with all of them was designed to help promote UK economic stability.

The new relationship with a different OBR is an opportunity for the Government, but a big risk too.



Source link

Continue Reading

Business

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

Published

on

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site


The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025.

Mike Blake | Reuters

Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the Trump administration to make the medicine more accessible.

The announcement also comes weeks after chief rival Novo Nordisk unveiled additional discounts on the cash prices of its obesity and diabetes drugs. 

Starting Monday, cash-paying patients with a valid prescription can get the starting dose of Zepbound vials for as low as $299 per month on LillyDirect, down from a previous price of $349 per month. They can also access the next dose, 5 milligrams, for $399 per month and all other doses for $449 per month, down from $499 per month across those sizes. 

Zepbound carries a list price of roughly $1,086 per month. That price point, and spotty insurance coverage for weight loss drugs in the U.S., have been significant barriers to access for some patients. 

Eli Lilly’s announcement comes just weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to get and afford. The agreements will cut the prices the government pays for the drugs, introduce Medicare coverage of obesity drugs for the first time for certain patients and offer discounted medicines on the government’s new direct-to-consumer website launching in January, TrumpRx. 

But Eli Lilly’s deal with Trump centers around lowering the prices of a different form of Zepbound – a multi-dose pen – after it wins Food and Drug Administration approval. 

That means Eli Lilly’s Monday announcement around cutting prices on the existing single-dose vials could allow more patients to get discounted treatments more quickly. 

“We will keep working to provide more options — expanding choices for delivery devices and creating new pathways for access — so more people can get the medicines they need,” said Ilya Yuffa, president of Lilly USA and global customer capabilities, in a statement. 

Eli Lilly’s stock, which has climbed more than 36% this year, fell nearly 2% on Monday. Its meteoric rise due to the success of Zepbound and its diabetes injection Mounjaro vaulted it to becoming the first health-care company to hit a $1 trillion market value last month. Though cutting prices means lower revenue per medication sold, Eli Lilly’s sales — and shares — have continued to soar through past pricing announcements as demand balloons.

With single-dose vials, patients need to use a syringe and needle to draw up the medicine and inject it into themselves. Eli Lilly first introduced that form of Zepbound in August 2024. 

It’s unclear how many patients are currently using single-dose vials of Zepbound. But Eli Lilly previously said that direct-to-consumer sales now account for more than a third of new prescriptions of Zepbound. 

Novo Nordisk earlier this month lowered the price of its obesity drug Wegovy and diabetes treatment Ozempic for existing cash-paying patients to $349 per month from $499 per month. That excludes the highest dose of Ozempic. 

The company also launched a temporary introductory offer, which will allow new cash-paying patients to access the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment. 



Source link

Continue Reading

Trending